Venture capital firm focused on building biotech companies.
Profile being verified
What they look for
Founded FERROSA in Basel in 2026 and led its USD 3.5 M seed; co-founding investor in ALLEGRIA Therapeutics.
Recent investments
Recorded Swiss rounds: ALLEGRIA Therapeutics (seed, USD 5.1 M, December 2025), FERROSA (seed, USD 3.5 M, April 2026, lead).
Rounds tracked by FundSwiss
- FERROSASeed · USD 3.5 M
- ALLEGRIA TherapeuticsSeed · USD 5.1 M